2026 Q2 -tulosraportti
14 päivää sitten
‧1 t 2 min
0,4074 USD/osake
Viimeisin osinko
2,69%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 5.8. | ||
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·12 min sittenSold my half a million in Novo, moved them to SanDisk, immediately got a gain of 29 percent. In just 3 days, I did lose 3 percent on novo, but my portfolio became more valuable. So now I can buy Novo with my profit, when it reaches the right level to buy again. Good luck to you all. May we all get something in the account
·1 päivä sittenI'm still holding onto my belief in Novo. Not because I think the stock will suddenly explode upwards, but because I still believe the company holds some of the strongest cards in hand within obesity and diabetes. Yes, the share price has taken a beating, and yes, there's more competition, but that doesn't change Novo's many years of research, strong products, know-how, and global position overnight. What I especially try to avoid is letting myself be influenced by all the profiles who constantly talk Novo down. Some of them don't even own the stock. Of course, it's perfectly fair to be critical, but I'd much rather listen to facts, results, and the company's development than to people who create fear and drama. I'm not buying Novo because the stock is popular right now. I'm buying it because I believe in the company in the long term. For me, the question is therefore not why Novo is falling right now, but where Novo will stand in 3-5 years if they continue to develop new treatments and gain market share. I still believe there's a lot of potential. You don't have to agree with me, but I'd rather stick to my own analysis than let myself be scared by people who shout the loudest. Novo will come back 📈
·12.8. · MuokattuI really can't understand why there isn't more focus on Awiqli and that it's now being sold in the USA.. It seems like everything is now about fat percentages.. I asked AI: Awiqli from Novo Nordisk is the world's first weekly basal insulin. The active substance in the medicine is called insulin icodec. The drug is designed to replace traditional long-acting insulins, which patients normally have to inject themselves with every single day. Important details about Awiqli. Fewer injections: With the new drug, the number of annual insulin injections is significantly reduced from 365 to 52 injections per year. Target group: It is primarily approved for adults with type 2 diabetes. For type 1 diabetes, it must always be combined with rapid-acting mealtime insulin. Effect: The insulin is released slowly and steadily into the body over seven days because the molecule binds to the protein albumin in the blood.
·5.8.I bought NN for 44,02 dollar - 285 DK last night now we'll have to see if it was a good idea?
Eli Lilly has been a better business since February 5th this year compared to Novo, even though Novo is ahead today. Over 5 years, EL takes off completely, but over the total period they have both been on the stock exchange, it is Novo that has risen the most, actually 5-6 x so much better than EL.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
14 päivää sitten
‧1 t 2 min
0,4074 USD/osake
Viimeisin osinko
2,69%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·12 min sittenSold my half a million in Novo, moved them to SanDisk, immediately got a gain of 29 percent. In just 3 days, I did lose 3 percent on novo, but my portfolio became more valuable. So now I can buy Novo with my profit, when it reaches the right level to buy again. Good luck to you all. May we all get something in the account
- ·1 päivä sittenI'm still holding onto my belief in Novo. Not because I think the stock will suddenly explode upwards, but because I still believe the company holds some of the strongest cards in hand within obesity and diabetes. Yes, the share price has taken a beating, and yes, there's more competition, but that doesn't change Novo's many years of research, strong products, know-how, and global position overnight. What I especially try to avoid is letting myself be influenced by all the profiles who constantly talk Novo down. Some of them don't even own the stock. Of course, it's perfectly fair to be critical, but I'd much rather listen to facts, results, and the company's development than to people who create fear and drama. I'm not buying Novo because the stock is popular right now. I'm buying it because I believe in the company in the long term. For me, the question is therefore not why Novo is falling right now, but where Novo will stand in 3-5 years if they continue to develop new treatments and gain market share. I still believe there's a lot of potential. You don't have to agree with me, but I'd rather stick to my own analysis than let myself be scared by people who shout the loudest. Novo will come back 📈
- ·12.8. · MuokattuI really can't understand why there isn't more focus on Awiqli and that it's now being sold in the USA.. It seems like everything is now about fat percentages.. I asked AI: Awiqli from Novo Nordisk is the world's first weekly basal insulin. The active substance in the medicine is called insulin icodec. The drug is designed to replace traditional long-acting insulins, which patients normally have to inject themselves with every single day. Important details about Awiqli. Fewer injections: With the new drug, the number of annual insulin injections is significantly reduced from 365 to 52 injections per year. Target group: It is primarily approved for adults with type 2 diabetes. For type 1 diabetes, it must always be combined with rapid-acting mealtime insulin. Effect: The insulin is released slowly and steadily into the body over seven days because the molecule binds to the protein albumin in the blood.
- ·5.8.I bought NN for 44,02 dollar - 285 DK last night now we'll have to see if it was a good idea?Eli Lilly has been a better business since February 5th this year compared to Novo, even though Novo is ahead today. Over 5 years, EL takes off completely, but over the total period they have both been on the stock exchange, it is Novo that has risen the most, actually 5-6 x so much better than EL.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 5.8. | ||
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 |
2026 Q2 -tulosraportti
14 päivää sitten
‧1 t 2 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 5.8. | ||
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 |
0,4074 USD/osake
Viimeisin osinko
2,69%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·12 min sittenSold my half a million in Novo, moved them to SanDisk, immediately got a gain of 29 percent. In just 3 days, I did lose 3 percent on novo, but my portfolio became more valuable. So now I can buy Novo with my profit, when it reaches the right level to buy again. Good luck to you all. May we all get something in the account
- ·1 päivä sittenI'm still holding onto my belief in Novo. Not because I think the stock will suddenly explode upwards, but because I still believe the company holds some of the strongest cards in hand within obesity and diabetes. Yes, the share price has taken a beating, and yes, there's more competition, but that doesn't change Novo's many years of research, strong products, know-how, and global position overnight. What I especially try to avoid is letting myself be influenced by all the profiles who constantly talk Novo down. Some of them don't even own the stock. Of course, it's perfectly fair to be critical, but I'd much rather listen to facts, results, and the company's development than to people who create fear and drama. I'm not buying Novo because the stock is popular right now. I'm buying it because I believe in the company in the long term. For me, the question is therefore not why Novo is falling right now, but where Novo will stand in 3-5 years if they continue to develop new treatments and gain market share. I still believe there's a lot of potential. You don't have to agree with me, but I'd rather stick to my own analysis than let myself be scared by people who shout the loudest. Novo will come back 📈
- ·12.8. · MuokattuI really can't understand why there isn't more focus on Awiqli and that it's now being sold in the USA.. It seems like everything is now about fat percentages.. I asked AI: Awiqli from Novo Nordisk is the world's first weekly basal insulin. The active substance in the medicine is called insulin icodec. The drug is designed to replace traditional long-acting insulins, which patients normally have to inject themselves with every single day. Important details about Awiqli. Fewer injections: With the new drug, the number of annual insulin injections is significantly reduced from 365 to 52 injections per year. Target group: It is primarily approved for adults with type 2 diabetes. For type 1 diabetes, it must always be combined with rapid-acting mealtime insulin. Effect: The insulin is released slowly and steadily into the body over seven days because the molecule binds to the protein albumin in the blood.
- ·5.8.I bought NN for 44,02 dollar - 285 DK last night now we'll have to see if it was a good idea?Eli Lilly has been a better business since February 5th this year compared to Novo, even though Novo is ahead today. Over 5 years, EL takes off completely, but over the total period they have both been on the stock exchange, it is Novo that has risen the most, actually 5-6 x so much better than EL.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt